Medication trial for broken heart (Takotsubo) syndrome
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests an optimized medication approach for people diagnosed with Takotsubo (“broken heart”) syndrome. It may help clinicians find a safer and more effective treatment plan after this heart condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 18 or older
- You have a clinician diagnosis of Takotsubo syndrome with ejection fraction under 50%
- You can sign a written consent form to join the study
- You have not joined or been randomized in this trial before
- You don’t have other serious conditions expected to shorten life to less than 1 month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry studies people who have been diagnosed with Takotsubo syndrome (a temporary heart condition that can mimic a heart attack). It helps researchers learn about who gets it, what happens over time, and what factors may affect recovery.
This is a registry study that collects information from people diagnosed with takotsubo syndrome. It helps researchers better understand the condition and may improve care in the future.
This study looks at whether levels of air pollution are linked to Takotsubo syndrome (a temporary heart condition). It may help doctors understand what environmental factors could affect episodes and timing.
This trial looks at people with either a heart attack pattern called STEMI or a temporary heart condition called Takotsubo (stress-related heart weakness). It compares what is found during a planned heart artery scan (coronary angiography) within 12 hours, which may help doctors understand and manage these conditions sooner.
This study looks at treatment options for adults with significantly reduced heart pumping strength and extensive coronary artery disease. It may help people who are at higher risk due to widespread blocked heart arteries, but eligibility depends on recent heart events and bleeding risk.
This trial tests whether starting a beta-blocker (a heart medication that slows the heartbeat and lowers blood pressure) soon after Takotsubo syndrome diagnosis helps prevent complications. You may qualify if you were just diagnosed and have no other serious heart conditions.
Hear when a new Takotsubo Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.